Editas Medicine Eulerpool Ziņas

Editas Medicine Eulerpool News

Editas Medicine Akciju Ziņas

Editas Medicine tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Editas Medicine ziņas mēs apkopojam šeit.

• 18. oktobris ·

  Seeking Alpha
  Warning: EDIT is at high risk of performing badly
• 16. oktobris ·

  Seeking Alpha
  Warning: EDIT is at high risk of performing badly
• 15. oktobris ·

  Seeking Alpha
  Warning: EDIT is at high risk of performing badly
• 15. oktobris ·

  Thefly.com
  MaxCyte appoints Cynthia Collins to board of directors
• 12. oktobris ·

  Yahoo
  Editas Medicine, Inc. (NASDAQ:EDIT) is largely controlled by institutional shareholders who own 64% of the company
• 10. oktobris ·

  GuruFocus
  Editas Medicine (EDIT) Stock Plummets Amid Financial Struggles
• 7. oktobris ·

  TipRanks
  Wells Fargo Sticks to Their Buy Rating for Editas Medicine (EDIT)
• 7. oktobris ·

  GuruFocus
  Editas Medicine (EDIT) Shares Plunge Amid Biotech Sector Fluctuations
• 6. oktobris ·

  SeekingAlpha
  Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma
• 5. oktobris ·

  Yahoo
  Editas Medicine Secures $57M Deal for Gene-Editing Technology